Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Congleton Jon sold 75,000 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Congleton Jon (Director, Chief Executive Officer) sold 75,000 Mineralys Therapeutics, Inc. shares at an average US$26.27 for US$1.97M under a trading plan, leaving 705,051 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 75,000 shares
- Price
- US$26.27 average (US$25.50 to US$27.05)
- Value
- US$1.97M
- Holding after
- 705,051 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Sale | 19,364 | US$25.50 | 760,687 | Direct |
| Mar 31, 2026 | Common Stock | Sale | 55,183 | US$26.54 | 705,504 | Direct |
| Mar 31, 2026 | Common Stock | Sale | 453 | US$27.05 | 705,051 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Congleton Jon
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Congleton Jon · Jul 15, 2026
- Form 4 · Congleton Jon · Jun 30, 2026
- Form 4 · Congleton Jon · Apr 15, 2026
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026
- Form 4 · Karydas Daphne · Sep 17, 2026